Botchkina GI, Ju J, Savitt AG, et al. Abstract 3331: New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in colon and prostate CSCs. Cancer Res 2011; 70(8): 3331.
Kalantari E, Saadi FH, Asgari M, et al. Increased expression of ALDH1A1 in prostate cancer is correlated with tumor aggressiveness. applied immunohistochemistry & molecular morphology. AIMM 2016; 25(8): 592-8.
Pires MM, Emmert DM, Chmielewski JA, et al. ABCB1 and ABCG2: deciphering the role of human efflux proteins in cellular and tissue permeability. 2011; 85-126.
Bellone M, Caputo S. Crosstalk between prostate cancer stem cells and immune cells: implications for tumor progression and resistance to immunotherapy cancer stem cell resistance to targeted therapy. Springer 2019; pp. 173-221.
Jeter CR, Tang DG. Prostate tissue stem cells and prostate cancer progression. Translational medicine. Cancer 2016; 2: 215.
Meng X, Marquez R, Smith A, et al. Abstract 5692: Targeted inhibition of cancer stem cells by self-assembled miRNA-nanovectors. Cancer Res 2012; 72(8): 5692.
McConkey DJ, Choi W, Marquis L, et al. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev 2009; 28(3-4): 335-44.
Li C, Du Y, Yang Z, et al. GALNT1-mediated glycosylation and activation of sonic hedgehog signaling maintains the self-renewal and tumor-initiating capacity of bladder cancer stem cells. Cancer Res 2016; 76(5): 1273.
Y S, MK C, TR G. Inhibition of STAT signalling in bladder cancer by diindolylmethane- relevance to cell adhesion, migration and proliferation. Curr Cancer Drug Targets 2013; 13(1): 57-68.
Dalong C, Dingwei Y. Advances and future prospects of immunotherapy in bladder cancer. China Oncology 2018; 28(2): 81-7.
Ojha R, Singh SK, Bhattacharyya S. JAK-mediated autophagy regulates stemness and cell survival in cisplatin resistant bladder cancer cells. BBA - Gen Subjects 2016; 1860(11): 2484-97.
Bussolati B, Camussi G. Cancer stem cells and renal carcinoma 2012; 211-0.
Yun EJ, Zhou J, Lin CJ, et al. Abstract 3078: Epigenetic regulation of miR-138 confers cancer stem cell characteristics of renal cell carcinoma. Cancer Res 2015; 75(15): 3078.
Lai WD, Gu RG. Research progress of side population cells and renal cell carcinoma stem cells. ResearchGate 2015; 22: 1161-4.
Kumar R, Kannan RR, Verma AK, et al. Abstract 2788: High ALDH1, S phase fraction, p16 INK4A in esophageal squamous cell carcinoma could predict response to neoadjuvant chemotherapy. Cancer Res 2017; 77(13)(Suppl.): 2788.
Ozbek E, Calik G, Otunctemur A, et al. Stem cell markers aldehyde dehydrogenase type 1 and nestin expressions in renal cell. Cancer 2012; 84(1): 7-11.
Earwaker PL. Resistance mechanisms to mTOR inhibition in renal cancer. University of Oxford 2015.
Panka DJ, Arbeit RD, Mier JW. Abstract 4155: Regulation of MDSC trafficking and function in RCC by CXCR4 in the presence of a VEGF-R antagonist. Cancer Res 2016; 76(14): 4155.
Gironmichel J, Azzi S, Khawam K, et al. Interleukin-15 plays a central role in human kidney physiology and cancer through the γc signaling pathway. PLoS One 2012; 7(2): 1-14.
Murray MJ, Schönberger S. Biology of Germ Cell Tumors. Springer, Berlin: Heidleberg 2014.
RR M, WH C, VS F, et al. Immunohistochemical expression of cancer stem cell markers OCT3/4, NANOG, DPPA4, and CCND2 in testicular germ cell tumors. J Clin Oncol 2012; 30(5): 333.